Allergen Immunotherapy in Asthma: Still Promising Approach
DOI:
https://doi.org/10.46966/msjar.v6i2.271Keywords:
Allergen Immunotherapy, Asthma, Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)Abstract
Background: Asthma a common and important respiratory problem with considerable morbidity and mortality outcome had been thoroughly studied problem and despite being effective and safe in ameliorating asthma course, steroid treatment, usually through inhalation, remains unsatisfactory as their withdrawal will be followed with relapse of asthma.
Aim: To revise the rule of Allergen Immunotherapy in the form of Subcutaneous Immunotherapy (SCIT) or Sublingual Immunotherapy (SLIT) in asthma.
Results and Conclusions: Allergen immunotherapy has a disease‐modifying property and may prevent asthma onset and worsening and improves asthma symptoms in a good fraction of patients and because of safety of both procedures trial of AIT has to be considered in patients with chronic mild and moderate asthma.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Iman Jabbar Kadhim , Suaad Muhammed H. Rasheed
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
